About VORTA
VORTA is a company based in Pune (India) founded in 2015. It operates as a Product-as-a-Service. VORTA offers products and services including Vortex Cavitation Reactor and Process Stream Optimization. VORTA operates in a competitive market with competitors including Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group, among others.
- Headquarter Pune, India
-
Sectors
Environment
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Vivira Process Technologies Private Limited
- Date of Incorporation 24 Feb, 2015
- Jurisdiction Pune, Maharashtra, India
-
Annual Revenue
$92.14 K (USD)25.63as on Mar 31, 2019
-
Net Profit
$15.01 K (USD)-13.11as on Mar 31, 2019
-
EBITDA
$3.77 K (USD)-52.36as on Mar 31, 2019
-
Latest Funding Round
Not available
-
Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of VORTA
VORTA offers a comprehensive portfolio of products and services, including Vortex Cavitation Reactor and Process Stream Optimization.
A reactor enhancing efficiency in manufacturing processes.
Optimization of streams for better resource utilization.
Funding Insights of VORTA
Investors in VORTA
VORTA has secured backing from 1 investor, including angel investors. Prominent investors backing the company include Swati Pramod Ranade.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
SP
Swati Pramod Ranade |
-
|
Locked | Locked | Locked |
Investor details for VORTA
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by VORTA
Investment portfolio details for VORTA
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - VORTA
Detailed financials for VORTA
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Vorta Comparisons
Peer comparison for VORTA
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of VORTA
VORTA operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| Locked | Locked | Locked |
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
|
|
| Locked | Locked | Locked |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| Locked | Locked | Locked |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| Locked | Locked | Locked |
Dental implants and regenerative dentistry products are developed.
|
|
| Locked | Locked | Locked |
RNA-editing technologies are provided for precision medicine applications.
|
Detailed competitors of VORTA
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Vorta
Complete news archive for VORTA
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about VORTA
VORTA was founded in 2015 and raised its 1st funding round 4 years after it was founded.
VORTA is headquartered in Pune, India. It is registered at Pune, Maharashtra, India.
Annual revenue of VORTA is $92.14K as on Mar 31, 2019.
VORTA is engaged in improving operational efficiencies within the manufacturing sector through innovative vortex cavitation technology. Solutions are provided to various industries including oil gas, pharmaceuticals, and dairy, targeting process streams and waste valorization. The technology is applied to enhance productivity, reduce waste, and promote sustainability by maximizing resource utilization. Operations are supported across multiple sectors to address challenges like aging infrastructure and compliance constraints, contributing to the transition towards a circular economy.
VORTA's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
VORTA offers Vortex Cavitation Reactor and Process Stream Optimization.
VORTA has 1 investor. Key investors include Swati Pramod Ranade.
The valuation of VORTA is $36.84K as of Dec 2019.